Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis — Stella

Recruiting

Back to Psoriatic Arthritis trials

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(1 site)

United States

First OC Dermatology Research Inc., Fountain Valley, California

Key details

Phase

Large-scale testing

Sponsor

Takeda

Enrollment target

~1,182 participants

Started

March 2026

Primary completion

December 2029

Age range

18 Years and older

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov